Jasper Bos
MS Ventures - Chairman
Biopharma
Calypso Biotech
Switzerland
Biography
Jasper Bos, PhD, is Director with MS Ventures, the corporate venture capital fund of Merck Serono SA, which invests in early stage and start-up biotech and pharmaceutical companies.​​​ ​Prior to joining Merck Serono SA, Jasper was instrumental in the founding of IFHA, a private equity fund backed by large Dutch and international institutional investors. ​ ​He was instrumental in the structuring and capital raise of IFHA and negotiated and managed private equity investments in emerging economies in the healthcare and insurance sectors. Before IFHA, Jasper worked as health economics and strategy manager at the Netherlands Vaccine Institute. Currently, he is a Member of the Board of Directors of EpiTherapeutics AS, Galecto Biotech, Neviah Genomics and an Observer to the Board of Vaximm AG. ​ He holds a PhD in Pharmacy from the University of Groningen, the Netherlands and has published more than 30 articles on health economics and vaccines.
Research Interest
​He was instrumental in the structuring and capital raise of IFHA and negotiated and managed private equity investments in emerging economies in the healthcare and insurance sectors. Before IFHA, Jasper worked as health economics and strategy manager at the Netherlands Vaccine Institute.
